310 related articles for article (PubMed ID: 29425714)
1. Leucyl-tRNA synthetase is required for the myogenic differentiation of C2C12 myoblasts, but not for hypertrophy or metabolic alteration of myotubes.
Sato Y; Sato Y; Suzuki R; Obeng K; Yoshizawa F
Exp Cell Res; 2018 Mar; 364(2):184-190. PubMed ID: 29425714
[TBL] [Abstract][Full Text] [Related]
2. The collagen derived dipeptide hydroxyprolyl-glycine promotes C2C12 myoblast differentiation and myotube hypertrophy.
Kitakaze T; Sakamoto T; Kitano T; Inoue N; Sugihara F; Harada N; Yamaji R
Biochem Biophys Res Commun; 2016 Sep; 478(3):1292-7. PubMed ID: 27553280
[TBL] [Abstract][Full Text] [Related]
3. Extracellular transglutaminase 2 induces myotube hypertrophy through G protein-coupled receptor 56.
Kitakaze T; Yoshikawa M; Kobayashi Y; Kimura N; Goshima N; Ishikawa T; Ogata Y; Yamashita Y; Ashida H; Harada N; Yamaji R
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118563. PubMed ID: 31666191
[TBL] [Abstract][Full Text] [Related]
4. The combination of ursolic acid and leucine potentiates the differentiation of C2C12 murine myoblasts through the mTOR signaling pathway.
Kim M; Sung B; Kang YJ; Kim DH; Lee Y; Hwang SY; Yoon JH; Yoo MA; Kim CM; Chung HY; Kim ND
Int J Mol Med; 2015 Mar; 35(3):755-62. PubMed ID: 25529824
[TBL] [Abstract][Full Text] [Related]
5. Guanidinoacetic Acid Regulates Myogenic Differentiation and Muscle Growth Through miR-133a-3p and miR-1a-3p Co-mediated Akt/mTOR/S6K Signaling Pathway.
Wang Y; Ma J; Qiu W; Zhang J; Feng S; Zhou X; Wang X; Jin L; Long K; Liu L; Xiao W; Tang Q; Zhu L; Jiang Y; Li X; Li M
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235878
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis.
Dogra C; Hall SL; Wedhas N; Linkhart TA; Kumar A
J Biol Chem; 2007 May; 282(20):15000-10. PubMed ID: 17383968
[TBL] [Abstract][Full Text] [Related]
7. 1,25(OH)2-vitamin D3 enhances the stimulating effect of leucine and insulin on protein synthesis rate through Akt/PKB and mTOR mediated pathways in murine C2C12 skeletal myotubes.
Salles J; Chanet A; Giraudet C; Patrac V; Pierre P; Jourdan M; Luiking YC; Verlaan S; Migné C; Boirie Y; Walrand S
Mol Nutr Food Res; 2013 Dec; 57(12):2137-46. PubMed ID: 23929734
[TBL] [Abstract][Full Text] [Related]
8. Palmitate induced insulin resistance by PKCtheta-dependent activation of mTOR/S6K pathway in C2C12 myotubes.
Wang X; Yu W; Nawaz A; Guan F; Sun S; Wang C
Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):657-61. PubMed ID: 20429048
[TBL] [Abstract][Full Text] [Related]
9. Regulation of protein synthesis by leucine starvation involves distinct mechanisms in mouse C2C12 myoblasts and myotubes.
Talvas J; Obled A; Fafournoux P; Mordier S
J Nutr; 2006 Jun; 136(6):1466-71. PubMed ID: 16702305
[TBL] [Abstract][Full Text] [Related]
10. Notch3 promotes 3T3-L1 pre-adipocytes differentiation by up-regulating the expression of LARS to activate the mTOR pathway.
Guo Y; Tan J; Xiong W; Chen S; Fan L; Li Y
J Cell Mol Med; 2020 Jan; 24(1):1116-1127. PubMed ID: 31755192
[TBL] [Abstract][Full Text] [Related]
11. Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotube maturation.
Park IH; Chen J
J Biol Chem; 2005 Sep; 280(36):32009-17. PubMed ID: 16043480
[TBL] [Abstract][Full Text] [Related]
12. A novel in vitro model for the assessment of postnatal myonuclear accretion.
Kneppers A; Verdijk L; de Theije C; Corten M; Gielen E; van Loon L; Schols A; Langen R
Skelet Muscle; 2018 Feb; 8(1):4. PubMed ID: 29444710
[TBL] [Abstract][Full Text] [Related]
13. The effect of caffeine on skeletal muscle anabolic signaling and hypertrophy.
Moore TM; Mortensen XM; Ashby CK; Harris AM; Kump KJ; Laird DW; Adams AJ; Bray JK; Chen T; Thomson DM
Appl Physiol Nutr Metab; 2017 Jun; 42(6):621-629. PubMed ID: 28177708
[TBL] [Abstract][Full Text] [Related]
14. Effects of 1,25(OH)2 D3 and 25(OH)D3 on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy.
van der Meijden K; Bravenboer N; Dirks NF; Heijboer AC; den Heijer M; de Wit GM; Offringa C; Lips P; Jaspers RT
J Cell Physiol; 2016 Nov; 231(11):2517-28. PubMed ID: 27018098
[TBL] [Abstract][Full Text] [Related]
15.
Eun SY; Chung CH; Cheon YH; Park GD; Lee CH; Kim JY; Lee MS
Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38785149
[TBL] [Abstract][Full Text] [Related]
16. Energy metabolism profile of the effects of amino acid treatment on skeletal muscle cells: Leucine inhibits glycolysis of myotubes.
Suzuki R; Sato Y; Obeng KA; Suzuki D; Komiya Y; Adachi SI; Yoshizawa F; Sato Y
Nutrition; 2020 Sep; 77():110794. PubMed ID: 32417723
[TBL] [Abstract][Full Text] [Related]
17. REV-ERBα activates the mTOR signalling pathway and promotes myotubes differentiation.
Dadon-Freiberg M; Chapnik N; Froy O
Biol Cell; 2020 Aug; 112(8):213-221. PubMed ID: 32306421
[TBL] [Abstract][Full Text] [Related]
18. IGF-1 Attenuates Hypoxia-Induced Atrophy but Inhibits Myoglobin Expression in C2C12 Skeletal Muscle Myotubes.
Peters EL; van der Linde SM; Vogel ISP; Haroon M; Offringa C; de Wit GMJ; Koolwijk P; van der Laarse WJ; Jaspers RT
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28862673
[TBL] [Abstract][Full Text] [Related]
19. Sodium fluoride induced skeletal muscle changes: Degradation of proteins and signaling mechanism.
Shenoy PS; Sen U; Kapoor S; Ranade AV; Chowdhury CR; Bose B
Environ Pollut; 2019 Jan; 244():534-548. PubMed ID: 30384060
[TBL] [Abstract][Full Text] [Related]
20. Distinct amino acid-sensing mTOR pathways regulate skeletal myogenesis.
Yoon MS; Chen J
Mol Biol Cell; 2013 Dec; 24(23):3754-63. PubMed ID: 24068326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
